Cochrane Japan gets independent Centre status

Cochrane Japan has been recognized for its outstanding achievements in promoting evidence-based decision-making in health care

Cochrane Japan has been recognized for its outstanding achievements in promoting evidence-based decision-making in health care by moving from a Cochrane Associate Centre to being awarded full, independent Centre status. 

The Centre consists of longstanding, dedicated Cochrane enthusiasts located at the National Centre for Child Health and Development (NCCHD) in Tokyo, Japan.

Cochrane Japan, part of Cochrane since 2014, will continue to promote evidence-based decision making in health care in Japan by supporting and training new authors of Cochrane Reviews, as well as working with clinicians, professional associations, policy-makers, patients, and the media to encourage the dissemination and use of Cochrane evidence.

 

Cochrane is a global independent network of researchers, professionals, patients, carers and people interested in health. Cochrane works with collaborators from more than 130 countries to produce credible, accessible health information that is free from commercial sponsorship and other conflicts of interest, and our evidence is recognized as representing an international gold standard for high-quality, trusted information.

Cochrane Japan’s Director Rintaro Mori says this is a hugely exciting opportunity: “The launch of Cochrane Japan as a full Centre is very important, both to Japan and globally. Japan is the world’s third-biggest economy with most developed healthcare sectors. The Centre has been recognized for its promotion of Cochrane evidence, produced and published in Japan, and this will not only simply increase the amount of evidence, but also promote sharing of clinical experiences across the region. In a time where this are concerns about misinformation on health topics in Japan, we are excited to increase our reach and highlight trusted Cochrane evidence.”

Rintaro Mori added, “This is an excellent opportunity for scientific growth, and gives us the chance to train students and a future generation that will develop high-quality research. Our chance to support health professionals in improving their decision-making based on the best available evidence will support patient care across Japan. We intend to collaborate in the dissemination of Cochrane Reviews and to continue supporting Cochrane to reach its 2020 strategic objectives.”

Cochrane’s CEO Mark Wilson, welcomed today’s news. “I am delighted we are announcing the launch of Cochrane Japan as a full Centre, the highest recognition of a Cochrane group. Cochrane Japan’s impact in dissemination, knowledge transfer, combined with their continued development of Cochrane authors, has been outstanding. Thanks to the growing base of our collaborators, and tremendous support from The National Centre for Child Health and Development (NCCHD) in Tokyo, we’re delighted to recognize these achievements, and now welcome them as one of 17 Cochrane Centres internationally, committed to the fullest range of Cochrane activities. The work of Dr Rintaro Mori and his team will deepen and expand the scope, reach, and impact of Cochrane activities on health and healthcare decision making not only in Japan but throughout Asia.”

For more information on the work of Cochrane Japan, please visit http://japan.cochrane.org/

Thursday, June 22, 2017
Share/Save